Titers read and immunity resolved.

Lab results read and interpreted against facility rules — immune, equivocal, or non-immune — with the follow-up path handled.

What it is

Titer results aren't binary: equivocal results, facility-specific cutoffs, and booster-versus-retest decisions trip up onboarding constantly. The agents read the lab report, apply the facility's acceptance rules, and when a result is non-immune, initiate the right follow-up — booster series or repeat draw — without a specialist untangling it.

How the agents run it · Health & Clinical Readiness

  1. 01

    Read

    Quantitative results are extracted from the lab report.

  2. 02

    Interpret

    Values are checked against the facility's immunity criteria — including equivocal handling.

  3. 03

    Route

    Non-immune results trigger the facility's follow-up path: booster, series, or declination process.

  4. 04

    Track

    Multi-step follow-ups (like a Hep B series) are tracked across their full timeline.

What you get

  • Equivocal results handled by rule, not guesswork
  • Booster series tracked across weeks without dropping
  • Facility cutoffs applied consistently

Questions

What happens when a titer comes back non-immune?

The agent applies the facility's rule — typically initiating a booster or vaccine series and scheduling the follow-up draw — and tracks the multi-week process to completion.

Which titers do facilities usually require?

Most commonly MMR (measles, mumps, rubella), varicella, and Hepatitis B surface antibody. The agents handle whichever the facility's matrix specifies, at its cutoff values.

See titers run live.

Thirty minutes, one placement, worked live — start to submit-ready.